Literature DB >> 21933714

Alterations in vasoconstrictor responses to the endothelium-derived contracting factor uridine adenosine tetraphosphate are region specific in DOCA-salt hypertensive rats.

Takayuki Matsumoto1, Rita C Tostes, R Clinton Webb.   

Abstract

Uridine adenosine tetraphosphate (Up(4)A) has been recently identified as a novel and potent endothelium-derived contracting factor and contains both purine and pyrimidine moieties, which activate purinergic P2X and P2Y receptors. The present study was designed to compare contractile responses to Up(4)A and other nucleotides such as ATP (P2X/P2Y agonist), UTP (P2Y(2)/P2Y(4) agonist), UDP (P2Y(6) agonist), and α,β-methylene ATP (P2X(1) agonist) in different vascular regions [thoracic aorta, basilar, small mesenteric, and femoral arteries] from deoxycorticosterone acetate-salt (DOCA-salt) and control rats. In DOCA-salt rats [vs. control uninephrectomized (Uni) rats]: (1) in thoracic aorta, Up(4)A-, ATP-, and UTP-induced contractions were unchanged; (2) in basilar artery, Up(4)A-, ATP-, UTP- and UDP-induced contractions were increased, and expression for P2X(1), but not P2Y(2) or P2Y(6) was decreased; (3) in small mesenteric artery, Up(4)A-induced contraction was decreased and UDP-induced contraction was increased; expression of P2Y(2) and P2X(1) was decreased whereas P2Y(6) expression was increased; (4) in femoral artery, Up(4)A-, UTP-, and UDP-induced contractions were increased, but expression of P2Y(2), P2Y(6) and P2X(1) was unchanged. The α,β-methylene ATP-induced contraction was bell-shaped and the maximal contraction was reached at a lower concentration in basilar and mesenteric arteries from Uni rats, compared to arteries from DOCA-salt rats. These results suggest that Up(4)A-induced contraction is heterogenously affected among various vascular beds in arterial hypertension. P2Y receptor activation may contribute to enhancement of Up(4)A-induced contraction in basilar and femoral arteries. These changes in vascular reactivity to Up(4)A may be adaptive to the vascular alterations produced by hypertension.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21933714      PMCID: PMC3264768          DOI: 10.1016/j.phrs.2011.09.005

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  57 in total

1.  P2Y(1), P2Y(2), P2Y(4), and P2Y(6) receptors are coupled to Rho and Rho kinase activation in vascular myocytes.

Authors:  V Sauzeau; H Le Jeune; C Cario-Toumaniantz; N Vaillant; A P Gadeau; C Desgranges; E Scalbert; P Chardin; P Pacaud; G Loirand
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-06       Impact factor: 4.733

2.  Enzymes that hydrolyze adenine nucleotides in diabetes and associated pathologies.

Authors:  Gilberto Inácio Lunkes; Daniela Lunkes; Francieli Stefanello; André Morsch; Vera Maria Morsch; Cinthia Melazzo Mazzanti; Maria Rosa Chitolina Schetinger
Journal:  Thromb Res       Date:  2003-02-15       Impact factor: 3.944

3.  Agonist-induced phosphorylation and desensitization of the P2Y2 nucleotide receptor.

Authors:  Rosa V Flores; Melvin G Hernández-Pérez; Edna Aquino; Richard C Garrad; Gary A Weisman; Fernando A Gonzalez
Journal:  Mol Cell Biochem       Date:  2005-12       Impact factor: 3.396

4.  Pharmacological characterization of nucleotide P2Y receptors on endothelial cells of the mouse aorta.

Authors:  Pieter-Jan D F Guns; András Korda; Herta M Crauwels; Tim Van Assche; Bernard Robaye; Jean-Marie Boeynaems; Hidde Bult
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

5.  Up4A stimulates endothelium-independent contraction of isolated rat pulmonary artery.

Authors:  Yu Gui; Michael P Walsh; Vera Jankowski; Joachim Jankowski; Xi-Long Zheng
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-01-11       Impact factor: 5.464

Review 6.  Purinergic regulation of vascular tone and remodelling.

Authors:  G Burnstock
Journal:  Auton Autacoid Pharmacol       Date:  2009-07

Review 7.  Dinucleoside polyphosphates and their interaction with other nucleotide signaling pathways.

Authors:  Esmerilda G Delicado; M Teresa Miras-Portugal; Luz María G Carrasquero; David León; Raquel Pérez-Sen; Javier Gualix
Journal:  Pflugers Arch       Date:  2006-05-11       Impact factor: 3.657

8.  Alterations in the modulation of cerebrovascular tone and blood flow by nitric oxide synthases in SHRsp with stroke.

Authors:  Noriko Daneshtalab; John S Smeda
Journal:  Cardiovasc Res       Date:  2009-12-15       Impact factor: 10.787

9.  Membrane-specific expression of functional purinergic receptors in normal human nasal epithelial cells.

Authors:  Chang-Hoon Kim; Sung-Shik Kim; Jae Young Choi; Ji-Hyun Shin; Jin Young Kim; Wan Namkung; Jeung-Gweon Lee; Min Goo Lee; Joo-Heon Yoon
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-06-18       Impact factor: 5.464

10.  NTPDase1 (CD39) controls nucleotide-dependent vasoconstriction in mouse.

Authors:  Gilles Kauffenstein; Annick Drouin; Nathalie Thorin-Trescases; Hélène Bachelard; Bernard Robaye; Pedro D'Orléans-Juste; François Marceau; Eric Thorin; Jean Sévigny
Journal:  Cardiovasc Res       Date:  2010-01-01       Impact factor: 10.787

View more
  19 in total

1.  Adenosine and its receptors as therapeutic targets: An overview.

Authors:  Sakshi Sachdeva; Monika Gupta
Journal:  Saudi Pharm J       Date:  2012-06-23       Impact factor: 4.330

Review 2.  Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes.

Authors:  Takayuki Matsumoto; Styliani Goulopoulou; Kumiko Taguchi; Rita C Tostes; Tsuneo Kobayashi
Journal:  Br J Pharmacol       Date:  2015-07-08       Impact factor: 8.739

3.  Impaired β-adrenoceptor-induced relaxation in small mesenteric arteries from DOCA-salt hypertensive rats is due to reduced K(Ca) channel activity.

Authors:  Takayuki Matsumoto; Theodora Szasz; Rita C Tostes; R Clinton Webb
Journal:  Pharmacol Res       Date:  2012-02-21       Impact factor: 7.658

4.  DOCA-salt hypertension impairs artery function in rat middle cerebral artery and parenchymal arterioles.

Authors:  Nusrat Matin; Paulo W Pires; Hannah Garver; William F Jackson; Anne M Dorrance
Journal:  Microcirculation       Date:  2016-10       Impact factor: 2.628

5.  UDP-induced relaxation is enhanced in aorta from female obese Otsuka Long-Evans Tokushima Fatty rats.

Authors:  Shota Kobayashi; Takayuki Matsumoto; Makoto Ando; Maika Iguchi; Shun Watanabe; Kumiko Taguchi; Tsuneo Kobayashi
Journal:  Purinergic Signal       Date:  2017-11-29       Impact factor: 3.765

Review 6.  Uridine adenosine tetraphosphate and purinergic signaling in cardiovascular system: An update.

Authors:  Zhichao Zhou; Takayuki Matsumoto; Vera Jankowski; John Pernow; S Jamal Mustafa; Dirk J Duncker; Daphne Merkus
Journal:  Pharmacol Res       Date:  2018-12-13       Impact factor: 7.658

7.  Mechanisms underlying uridine adenosine tetraphosphate-induced vascular contraction in mouse aorta: Role of thromboxane and purinergic receptors.

Authors:  Zhichao Zhou; Changyan Sun; Stephen L Tilley; S Jamal Mustafa
Journal:  Vascul Pharmacol       Date:  2015-04-25       Impact factor: 5.773

8.  Enhanced uridine adenosine tetraphosphate-induced contraction in renal artery from type 2 diabetic Goto-Kakizaki rats due to activated cyclooxygenase/thromboxane receptor axis.

Authors:  Takayuki Matsumoto; Shun Watanabe; Ryusuke Kawamura; Kumiko Taguchi; Tsuneo Kobayashi
Journal:  Pflugers Arch       Date:  2013-07-31       Impact factor: 3.657

Review 9.  The role of adenosine and adenosine receptors in the immunopathogenesis of multiple sclerosis.

Authors:  Elham Safarzadeh; Farhad Jadidi-Niaragh; Morteza Motallebnezhad; Mehdi Yousefi
Journal:  Inflamm Res       Date:  2016-03-09       Impact factor: 4.575

10.  Impaired UTP-induced relaxation in the carotid arteries of spontaneously hypertensive rats.

Authors:  Takayuki Matsumoto; Mihoka Kojima; Keisuke Takayanagi; Tomoki Katome; Kumiko Taguchi; Tsuneo Kobayashi
Journal:  Purinergic Signal       Date:  2020-08-29       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.